Federal
Register Notices > Importers
> Johnson Matthey, Inc.
FR Doc E7-25043 [Federal Register: December 27, 2007 (Volume 72, Number
247)] [Notices] [Page 73359] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27de07-75]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to Title 21 Code of Federal Regulations
1301.34(a), this is notice
that on November 7, 2007, Johnson Matthey, Inc., Pharmaceutical Materials,
2003 Nolte Drive, West Deptford, New Jersey 08066-1742, made application by
renewal to the Drug Enforcement Administration (DEA) for registration as an
importer of the basic classes of controlled substances listed in schedule II:
Drug
|
Schedule
|
Phenylacetone (8501)
|
II
|
Raw Opium (9600)
|
II
|
Concentrate of Poppy Staw (9670)
|
II
|
The company plans to import the listed controlled substances as raw
materials for use in the manufacture of bulk controlled substances for
distribution to its customers.
No comments, objections, or requests for any hearings will be accepted on
any application for registration or re-registration to import crude opium,
poppy straw, concentrate of poppy straw, or coca leaves.
Any bulk manufacturer who is presently, or is applying to be, registered
with DEA to manufacture such basic classes of controlled substances listed in
schedule I or II, which fall under the authority of section 1002(a)(2)(B) of
the Act (21 U.S.C.
952(a)(2)(B)) may, in the circumstances set forth in 21
U.S.C. 958(i), file comments or objections to the issuance of the proposed
registration and may, at the same time, file a written request for a hearing
on such application pursuant to 21 CFR 1301.43 and in such form as prescribed
by 21 CFR 1316.47.
Any such comments or objections being sent via regular mail should be
addressed, in quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative/ODL, Washington, DC 20537,
or any being sent via express mail should be sent to Drug Enforcement
Administration, Office of Diversion Control, Federal Register Representative/ODL,
8701 Morrissette Drive, Springfield, VA 22152; and must be filed no later than
January 28, 2008.
This procedure is to be conducted simultaneously with and independent of
the procedures described in 21 CFR Sec. 1301.34(b), (c), (d), (e) and (f). As
noted in a previous notice published in the Federal Register on September 23,
1975, (40 FR 43745), all applicants for registration to import a basic class
of any controlled substances in schedule I or II are, and will continue to be,
required to demonstrate to the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration, that the requirements for
such registration pursuant to 21
U.S.C. 958(a); 21
U.S.C. 823(a); and 21 CFR
1301.34(b), (c), (d), (e) and (f) are satisfied.
Dated: December 18, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-25043 Filed 12-26-07; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|